Post-approval studies (Phase 4)Active Not RecruitingNCT05118490
What this trial is testing
Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients
Who this might be right for
HIV SeropositivityTuberculosisHousehold Contact
The Aurum Institute NPC 1,000